Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study on the Safety and Efficacy of CRTKVA11-03 TCR-T Cell Injection in Patients With Advanced Solid Tumors

NCT07826585 is registered in ClinicalTrials.gov with Corregene Biotechnology Co., Ltd as lead sponsor.

NCT NCT07826585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07826585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study on the Safety and Efficacy of CRTKVA11-03 TCR-T Cell Injection in Patients With Advanced Solid Tumors
Lead sponsor
Corregene Biotechnology Co., Ltd
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 26, 2026
Completion date
December 31, 2029
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors